Albert Hagège

1989–2025 年に発表

別表記
Albert Hagege
96
論文数
22,334
被引用数
71
h 指数
91
i10 指数

被引用数

Albert Hagège の年別被引用数1967 年: 被引用 1 件1982 年: 被引用 1 件1986 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 3 件1993 年: 被引用 7 件1994 年: 被引用 14 件1995 年: 被引用 15 件1996 年: 被引用 7 件1997 年: 被引用 14 件1998 年: 被引用 39 件1999 年: 被引用 31 件2000 年: 被引用 15 件2001 年: 被引用 39 件2002 年: 被引用 49 件2003 年: 被引用 116 件2004 年: 被引用 98 件2005 年: 被引用 120 件2006 年: 被引用 117 件2007 年: 被引用 107 件2008 年: 被引用 84 件2009 年: 被引用 87 件2010 年: 被引用 82 件2011 年: 被引用 99 件2012 年: 被引用 83 件2013 年: 被引用 57 件2014 年: 被引用 94 件2015 年: 被引用 142 件2016 年: 被引用 166 件2017 年: 被引用 179 件2018 年: 被引用 217 件2019 年: 被引用 577 件2020 年: 被引用 656 件2021 年: 被引用 733 件2022 年: 被引用 497 件2023 年: 被引用 410 件2024 年: 被引用 702 件2025 年: 被引用 332 件2026 年: 被引用 9 件1968〜1981 年は被引用が無いため表示していません1983〜1985 年は被引用が無いため表示していません1987〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,910 件、この内訳の 20.9%イギリス: 引用元論文 806 件、この内訳の 8.8%イタリア: 引用元論文 709 件、この内訳の 7.8%フランス: 引用元論文 558 件、この内訳の 6.1%ドイツ: 引用元論文 519 件、この内訳の 5.7%中国: 引用元論文 480 件、この内訳の 5.2%オランダ: 引用元論文 371 件、この内訳の 4.1%カナダ: 引用元論文 317 件、この内訳の 3.5%スペイン: 引用元論文 310 件、この内訳の 3.4%日本: 引用元論文 282 件、この内訳の 3.1%オーストラリア: 引用元論文 234 件、この内訳の 2.6%スイス: 引用元論文 172 件、この内訳の 1.9%
0%20.9%その他 26.9%

分野

  • Medicine75%
  • Biochemistry, Genetics and Molecular Biology19.5%
  • Engineering2%
  • Neuroscience1.5%
  • Materials Science1.1%
  • Computer Science0.2%
  • その他0.7%

トピック

  • Cardiomyopathy and Myosin Studies10.8%
  • Cardiovascular Function and Risk Factors7.4%
  • Tissue Engineering and Regenerative Medicine5.6%
  • Cardiovascular Effects of Exercise4.5%
  • Congenital heart defects research3.3%
  • Mesenchymal stem cell research3%
  • その他65.4%

共著者

全論文

検索で開く
  1. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emeline M. Van Craenenbroeck, Miloš Kubánek, David Zemánek, Morten K. Jensen, Jens Mogensen, Jens Jakob Thune, Philippe Charron, Albert Hagège, Olivier Lairez, Jean‐Noël Trochu, Christoph Axthelm, H DUENGEN, Norbert Frey, Veselin Mitrović, Michael R. Preusch, Jeanette Schulz‐Menger, Tim Seidler, Michael Arad, Majdi Halabi, Amos Katz, Daniel Monakier, Offir Paz, Samuel Viskin, Donna R. Zwas, Iacopo Olivotto, Hans‐Peter Brunner‐La Rocca, Michelle Michels, Dariusz Dudek, Zofia Oko‐Sarnowska, Artur Oręziak, Wojciech Wojakowski, Nuno Cardim, Helder Pereira, Roberto Barriales‐Villa, Pablo García Pavía, Juan Gimeno Blanes, Rafael Hidalgo Urbano, Luis Miguel Rincón Diaz, Perry Elliott, Zaheer Yousef, Theodore P. Abraham, Kia Afshar, Paulino Álvarez, Richard G. Bach, Richard C. Becker, Lubna Choudhury, David Fermin, Daniel Jacoby, John L. Jefferies, Christopher M. Kramer, Neal K. Lakdawala, Steven J. Lester, Ali J. Marian, Ahmad Masri, Matthew J. Maurer, Sherif F. Nagueh, Anjali Owens, David S. Owens, Florian Rader, Sara Saberi, Mark V. Sherrid, Jamshid Shirani, John D. Symanski, Aslan T. Turer, Andrew Wang, Omar Wever‐Pinzon, Matthew T. Wheeler, Timothy C. Wong, Mohamad H. Yamani - The Lancet 2020 被引用: 1,210

  2. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2014 被引用: 4,317

  3. Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Meng, Amy Wohltman, Theodore P. Abraham - New England Journal of Medicine 2024 被引用: 282

  4. Cardiac Involvement in Fabry Disease

    著者: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2021 被引用: 309

  5. Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction

    著者: , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 被引用: 442

  6. An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease

    著者: , , , , , , , , , , , , - European Journal of Heart Failure 2020 被引用: 219

  7. Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicolas Sadoul, Xavier Waintraub, Khadija Chikhaoui, Philippe Mabo, Nicolas Combes, Philippe Maury, Jean‐Marc Sellal, Usha B. Tedrow, Jonathan M. Kalman, Jitendra K. Vohra, Alexander F.A. Androulakis, Katja Zeppenfeld, Tina Thompson, Christine Barnérias, Henri-Marc Bécane, Éric Bieth, Franck Boccara, Damien Bonnet, Françoise Bouhour, Stéphane Boulé, Anne‐Claire Bréhin, Françoise Chapon, Pascal Cintas, Jean‐Marie Cuisset, Jean‐Marc Davy, Annachiara De Sandre‐Giovannoli, Florence Démurger, Isabelle Desguerre, Klaus Dieterich, Julien Durigneux, Andoni Echaniz‐Laguna, Romain Eschalier, Ana Ferreiro, Xavier Ferrer, Christine Francannet, Mélanie Fradin, Bénédicte Gaborit, Arnaud Gay, Albert Hagège, Arnaud Isapof, Isabelle Jéru, Raúl Juntas Morales, Emmanuelle Lagrue, Nicolas Lamblin, Olivier Lascols, Vincent Laugel, Arnaud Lazarus, France Leturcq, Nicolas Lévy, Armelle Magot, Véronique Manel, Raphaël P. Martins, M. Mayer, Sandra Mercier, Christophe Meune, Maud Michaud, Marie-Christine Minot-Myhié, Antoine Muchir, Aleksandra Nadaj‐Pakleza, Yann Péréon, Philippe Petiot, Florence Petit, Julien Praline, Anne Rollin, Pascal Sabouraud, Catherine Sarret, S. Schaeffer, Frédéric Taithe, Céline Tard, V. Tiffreau ほか 10 名 - Circulation 2019 被引用: 260

  8. X‐chromosome inactivation in female patients with Fabry disease

    著者: , , , , , , , , , - Clinical Genetics 2015 被引用: 417

  9. Myocardial Stiffness Evaluation Using Noninvasive Shear Wave Imaging in Healthy and Hypertrophic Cardiomyopathic Adults

    著者: , , , , , , , , , , , - JACC. Cardiovascular imaging 2018 被引用: 182

  10. Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - JACC Heart Failure 2023 被引用: 46

  11. Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , - European Heart Journal 2024 被引用: 94

  12. Mitral valve disease—morphology and mechanisms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Russell A. Norris, David S. Peal, M. Perrocheau, Vincent Probst, Michael Pucéat, Nadia Rosenthal, Jorge Solı́s, Jean‐Jacques Schott, Ehud Schwammenthal, Susan A. Slaugenhaupt, Jae‐Kwan Song, Magdi H. Yacoub, for the Leducq Mitral Transatlantic Network - Nature Reviews Cardiology 2015 被引用: 383

  13. Cardiovascular progenitor–derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure

    著者: , , , , , , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2016 被引用: 198

  14. Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors

    著者: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2018 被引用: 165

  15. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report: Figure 1

    著者: , , , , , , , , , , , , , , , , , - European Heart Journal 2015 被引用: 434

  16. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Songsak Kiatchoosakun, Kee‐Sik Kim, Ömer Kozan, Edmundo Bayram Llamas, Felipe Martínez, Béla Merkely, Iván Mendoza, Arend Mosterd, Marta Negrusz‐Kawecka, Keijo Peuhkurinen, Félix José Alvarez Ramires, Jens Refsgaard, Arvo Rosenthal, Michele Senni, Antonio S. Sibulo, José Silva‐Cardoso, Iain Squire, Randall C. Starling, John R. Teerlink, Johan Vanhaecke, Dragoş Vinereanu, Raymond Wong - Circulation 2014 被引用: 667

  17. Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness

    著者: , , , , , , , , , , , , , , , , , - European Heart Journal 2015 被引用: 243

  18. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial

    著者: , , , , , , , , , , , , , , - Circulation 2008 被引用: 943

  19. Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Levine, Emelia J. Benjamin, Ramachandran S. Vasan, Benjamin D. Horne, Joseph B. Muhlestein, Giovanni Benfari, Maurice Enriquez‐Sarano, Andrea Natale, Sanghamitra Mohanty, Chintan Trivedi, Moore B. Shoemaker, Zachary T. Yoneda, Quinn S. Wells, Michael Baker, Eric Farber‐Eger, Héctor I. Michelena, Alicia Lundby, Russell A. Norris, Susan Slaugenhaupt, Christian Dina, Steven A. Lubitz, Nabila Bouatia‐Naji, Patrick T. Ellinor, David J. Milan - European Heart Journal 2022 被引用: 70

  20. Serial left ventricular adaptations in world-class professional cyclists

    著者: , , , , , , - Journal of the American College of Cardiology 2004 被引用: 253

  21. Effect of Losartan on Mitral Valve Changes After Myocardial Infarction

    著者: , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2017 被引用: 123

  22. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Glikson, Alastair Gray, Meral Kayıkçıoğlu, Aldo P. Maggioni, Klaudia Vivien Nagy, Aleksandr Nedoshivin, Anna-Sonia Petronio, Jolien Roo Hesselink, Lars Wallentin, Uwe Zeymer, Alida Caforio, Juan R. Gimeno, Philippe Charron, Perry Elliott, Juan Pablo Kaski, Aldo P. Maggioni, Luigi Tavazzi, Michał Tendera, С. М. Комиссарова, Н. Н. Чакова, S. S. Niyazova, Aleš Linhart, Petr Kuchynka, T Palecek, Jana Podzimková, Marek Fikrle, Eneida R. Nemecek, Henning Bundgaard, Jacob Tfelt‐Hansen, Juliane Theilade, Jens Jakob Thune, Å.B. Axelsson, Jens Mogensen, F.L. Henriksen, Thomas Morris Hey, Søren K. Nielsen, Lars Videbæk, Simon Andreasen, H Arnsted, Anas M. Saad, Muzaffar Ali, Jyri Lommi, Tiina Heliö, M S Nieminen, Olivier Dubourg, Nicolas Mansencal, Murat Nihat Arslan, V. Siam Tsieu, Thibaud Damy, Aziz Guellich, Soulef Guendouz, Claire Marie Tissot, Aurélia Lamine, Stéphane Rappeneau, Albert Hagège, Michel Desnos, A Bachet, M. Hamzaoui, Philippe Charron, R Isnard, L. Legrand, Carole Maupain, Estelle Gandjbakhch, Mathieu Kernéis, J.F. Pruny, Anna Bauer, Barbara Pfeiffer, S B Felix, Marcus Dörr, S Kaczmarek ほか 277 名 - European Heart Journal - Quality of Care and Clinical Outcomes 2022 被引用: 44

  23. First-in-man use of a cardiovascular cell-derived secretome in heart failure. Case report

    著者: , , , , , , , , , , , , , - EBioMedicine 2024 被引用: 34

  24. Primary cilia defects causing mitral valve prolapse

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ronen Durst, Roger R. Markwald, Solena Le Scouarnec, Albert Hagège, Thierry Le Tourneau, Peter Köhl, Eva A. Rog‐Zielinska, Patrick T. Ellinor, Robert A. Levine, David J. Milan, Jean‐Jacques Schott, Nabila Bouatia‐Naji, Susan A. Slaugenhaupt, Russell A. Norris - Science Translational Medicine 2019 被引用: 112